Pegaptanib blev undersøgt i 2 kontrollerede dobbeltblindede og identisk designede randomiserede studier (EOP1003, EOP1004) hos patienter med neovaskulær AMD.
Pegaptanib was studied in two controlled, double-masked, and identically designed randomised studies (EOP1003; EOP1004) in patients with neovascular AMD.